BioSpace News Archive

Iaso Therapeutics announced it has received a $978,597 grant from the National Science Foundation (NSF).

Stonegate Capital Partners is hosting a webcast for Palisade Bio (NASDAQ: PALI) to discuss clinical data on LB1148, an investigational treatment of post-surgical abdominal adhesions.

AMRA’s recent research, performed in collaboration with Daiichi Sankyo and the National Center of Neurology and Psychiatry (NCNP) in Japan, will be presented at the 2022 MDA Clinical & Scientific Conference scheduled for March 13 - 16.

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), today announced a $50,000 award to the University of Pennsylvania’s Center for Inherited Cardiovascular Disease to support the development of a dedicated cardiac care clinic for female carriers of Duchenne and Becker muscular dystrophy.

According to Precedence Research, the global blood pressure monitoring devices market size is expected to be worth around US$ 2.66 billion by 2027 and growing at a CAGR 8.56% from 2022 to 2027.

The global continuous glucose monitoring device market was estimated at USD 4.7 billion in 2021 and is expected to reach over USD 10.34 billion by 2030, poised to grow at a compound annual growth rate (CAGR) of 9.2% during the forecast period 2021 to 2030.

The global digital health market size is expected to be worth around US$ 551.09 billion by 2027 and poised to grow at a CAGR 16.5% from 2022 to 2027, according to Precedence Research.

The global smart healthcare market size is expected to hit US$ 482.25 billion by 2027 from valued at US$ 145.32 billion in 2020, poised to grow at a CAGR of 19.7% between 2020 and 2027.

Applied BioCode today announced an agreement with Hardy Diagnostics, a leader in manufactured and distributed microbiology products in the United States, for the distribution of the MDx-3000 System and its comprehensive menu for the diagnosis of upper respiratory infections, gastrointestinal infections as well as a suite of Analyte Specific Reagents (ASRs) which can be used by high-complexity laboratories to develop their own laboratory developed tests (LDTs).

Breg, Inc., a leading orthopedic bracing and billing services company, announced that its board of directors has appointed Kevin Hobert president and CEO.